AzaSite is effective against bacterial conjunctivitis using reduced dosing frequency Dec. 2, 2005 No Comments
Recent Jerini patent describes novel therapeutic agents for eye, skin and joint disorders Nov. 10, 2005 No Comments
A second phase III study confirms the therapeutic benefits of ranibizumab in AMD Nov. 9, 2005 No Comments
RSS